Evaluation of the stability of circulating nucleotides and microvesicles as biomarkers for cardiovascular diseases

Evaluation of the stability of circulating nucleotides and microvesicles as biomarkers for cardiovascular diseases - Evaluation of the stability of circulating nucleotides and microvesicles as biomarkers for cardiovascular diseases

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000033959

Enrollment

194

Registered

2018-11-20

Start date

2019-03-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation, atherosclerotic disease

Interventions

Intake of food, one time

Sponsors

Tokyo Medical and Dental University

Lead Sponsor

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1 Healthy subjects 2 Patients who regularly visiting Tokyo Medical and Dental University Medical hospital and who are diagnosed as having atrial fibrillation or endothelial dysfunction

Exclusion criteria

Exclusion criteria: Subjects who have malignancy, autoimmune diseases, or severe anemia (Hb<10.9)

Design outcomes

Primary

Measure	Time frame
The diurnal change and the effect of diet in the expression level of circulating nucleotides.	—

Countries

Japan

Contacts

Public ContactTetsuo Sasano

Tokyo Medical and Dental University Department of Cardiovascular Medicine

sasano.bi@tmd.ac.jp03-5803-5231

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026